Abstract
The three aspects influencing risk of clotting—Virchow’s Triad—include venous stasis, vessel injury, and hypercoagulable states or thrombophilias (Fig. 13.1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med. 2003;138:128–34.
Cushman M. Inherited risk factors for venous thrombosis. Hematology Am Soc Hematol Educ Program. 2005;2005:452–7.
Caprini JA, Glase CJ, Anderson CB, Hathaway K. Laboratory markers in the diagnosis of venous thromboembolism. Circulation. 2004;109(suppl I):I-4–8.
Moll S. Thrombophilias – practical implications and testing caveats. J Thromb Thrombolysis. 2006;21:7–15.
Kottke-Marchant K, Duncan A. Antithrombin deficiency: issues in laboratory diagnosis. Arch Pathol Lab Med. 2002;126:1326–36.
Dager WE, Gosselin RC, Owings JT. Argatroban therapy for antithrombin deficiency and mesenteric thrombosis: case report and review of the literature. Pharmacotherapy. 2004;24:659–63.
Goodwin AJ, Rosendaal FR, Kottke-Marchant K, Bovill E. A review of the technical, diagnostic, and epidemiologic considerations for protein S assays. Arch Pathol Lab Med. 2002;126:1349–66.
Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med. 2002;126:1304–18.
McGlennen RC, Key NS. Clinical and laboratory management of the prothrombin G20210A mutation. Arch Pathol Lab Med. 2002;126:1319–25.
Chandler WL, Rodgers GM, Sprouse JT, Thompson AR. Elevated hemostatic factor levels as potential risk factors for thrombosis. Arch Pathol Lab Med. 2002;126:1405–14.
Key NS, McGlennen RC. Hyperhomocyst(e)inemia and thrombophilia. Arch Pathol Lab Med. 2002;126:1367–75.
Bønaa KH, Njølstad I, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578–88.
Den Heijer M, Willems HPJ, Blom HJ, et al. Homocysteine lowering by B vitamins and the secondary prevention of deep-vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double blind trial. Blood. 2007;109:139–44.
The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567–77.
Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA. 2004;291:565–75.
Brandt J. Plasminogen and tissue-type plasminogen activator deficiency as risk factors for thromboembolic disease. Arch Pathol Lab Med. 2002;126:1376–81.
Francis CW. Plasminogen activator inhibitor-1 levels and polymorphisms: association with venous thromboembolism. Arch Pathol Lab Med. 2002;126:1401–4.
Hayes T. Dysfibrinogenemia and thrombosis. Arch Pathol Lab Med. 2002;126:1387–90.
Kitchens C. The contact system. Arch Pathol Lab Med. 2002;126:1382–6.
Tollefsen DM. Heparin cofactor II deficiency. Arch Pathol Lab Med. 2002;126:1394–400.
Dalen JE. Should patients with venous thromboembolism be screened for thrombophilia ? Am J Med. 2008;121:458–63.
Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia. Arch Intern Med. 2006;166:729–36.
Kearon C, Kahn SR, Agnelli G. Antithrombotic therapy for venous thromboembolic disease. Chest. 2008;133:454S–545.
Van Cott EM, Laposata M, Prins MH. Laboratory evaluation of hypercoagulability with venous or arterial thrombosis. Arch Pathol Lab Med. 2002;126:1281–95.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Nutescu, E.A., Michaud, J.B., Caprini, J.A., Caprini, J.A. (2013). Genetic Thrombophilias: When to Consider and What to Do. In: Sadick, N., Khilnani, N., Morrison, N. (eds) Practical Approach to the Management and Treatment of Venous Disorders. Springer, London. https://doi.org/10.1007/978-1-4471-2891-5_13
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2891-5_13
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2890-8
Online ISBN: 978-1-4471-2891-5
eBook Packages: MedicineMedicine (R0)